RDIF and Serum Institute of India, the world’s largest vaccine manufacturer by volume, to start production of Sputnik vaccine at Company’s facilities in September
Technology transfer process has already started; cultivation process has begun following the approval by the Drug Controller General of India (DCGI). The parties intend to produce over 300 million doses of the vaccine in India per year with the first batch expected in September 2021. Moscow, July 13, 2021 – The Russian Direct Investment Fund …